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To the Editor: Each year, nonpolio enteroviruses 
cause 10–15 million infections in the United States (1). 













patient contact, n = 30† 
Without	direct	patient	
contact, n = 40‡ 
t-value	or	
odds	ratio§ p	value 
Demographic	      
 Mean	(SD)	age,	y 38	(8.3) 35	(9.9)  1.10 0.29 
 Male	sex,	no.	(%) 16	(55) 12	(30)  0.35 0.05 
 Living	with	partner,	no	(%) 22 (76) 22	(55)  0.39 0.08 
 Occupation,	no.	(%)      
  Physician 9	(31) 11	(28)  0.89 1.00 
  Nurse 19	(66) 26	(65)    
Self-report	scale,	mean	(SD)¶	      
 Somatic	symptom	severity,	SSS-8 5.03	(3.4) 4.74	(4.9)  0.30 0.77 
 Anxiety	severity,	GAD-7 2.43	(2.7) 2.41	(2.0)  0.03 0.98 
 Depression	severity,	PHQ-9 3.52	(3.3) 3.38	(3.0)  0.18 0.86 
 Fatigue	symptoms,	Facit 12.88	(9.1) 13.32	(8.1)  0.20 0.84 
 Social	isolation 0.62	(0.9) 0.00	(0.0)  3.70 <0.001 
Evaluation	of	working	conditions,	no.	(%)      
 Had	confidence	in	health	care	facilities 29	(97) 26	(93)  2.20 0.61 
 Desired	psychological	preparation 7	(26) 16	(52)  0.33 0.06 
 Desired	shorter	shift	durations 16	(70) 5	(28)  5.70 0.01 
 Experienced	treatment	with	Ebola	patient	as	an 
    exceptional	circumstance	 
22	(85) 18	(64)  2.99 0.12 
*Facit,	Functional	Assessment	of	Chronic	Illness	Therapy;	GAD-7,	Generalized	Anxiety	Disorder	Scale-7;	PHQ-9,	Patient	Health	Questionnaire-9;	SSS-8,	 
Somatic	Symptom	Scale-8. 
†Because of missing values, no. patients varied between 26 and 30. 




nonpolio enterovirus that emerged in Illinois and Missouri 
in August 2014 in association with severe respiratory infec-
tions in children and spread across the United States (2). 
On August 23, 2014, the infection control department for 
Comer’s Children’s Hospital at the University of Chicago 
initially notified the Centers for Disease Control and Pre-
vention of an increased number of children hospitalized 
with unusually severe respiratory illness (3). From mid-
August to December 4, 2014, there were 1,121 laboratory-
confirmed cases of EV-D68 in the United States (2). Almost 
all EV-D68 infections have occurred in children, many of 
whom had a history of asthma or wheezing (2).
One day before the first report (August 22, 2014), a 
26-year-old obese woman with an unremarkable medi-
cal history was transferred to the medical intensive care 
unit at Saint Francis Medical Center, a tertiary care medi-
cal center in Peoria, Illinois, USA, with severe acute 
respiratory distress syndrome (ARDS). The transfer 
was from a nearby community hospital where she had 
sought care 4 days earlier for influenza-like symptoms 
consisting of cough, wheezing, progressive shortness 
of breath, nausea, and vomiting. In the community hos-
pital emergency department, she mentioned that 2 chil-
dren at home had similar symptoms and that her mother 
had recently been hospitalized with an acute respiratory 
illness. Despite treatment with supplemental oxygen, 
nebulized albuterol, and intravenous antimicrobial drugs 
for community-acquired pneumonia, her condition dete-
riorated, and she was intubated on hospital day 2, after 
which the antimicrobial drug treatment was changed from 
intravenous ceftriaxone and azithromycin to intravenous 
vancomycin and piperacillin/tazobactam. Results of bron-
choscopy performed on hospital day 4 were unremark-
able, and bacterial cultures of alveolar lavage samples 
were negative.
Her transfer to St. Francis Medical Center was prompt-
ed by persistent mechanical ventilation requirements of 
100% fraction of inspired oxygen; positive end-inspirato-
ry pressure of 12 mm/H2O consistent with classic ARDS 
(hypoxemia, indicated by a ratio of arterial oxygen partial 
pressure to fractional inspired oxygen <200 mm Hg); and 
bilateral infiltrates on chest radiograph (Figure) without ev-
idence of left heart failure (4). On hospital day 8 (cumula-
tive), a nasopharyngeal swab sample was tested by FilmAr-
ray Respiratory Panel multiplex PCR (BioFire Diagnostics, 
Salt Lake City, UT, USA); results were positive for rhinovi-
rus/enterovirus. That day, intravenous methylprednisolone 
therapy was initiated.
During a prolonged hospital stay, the patient required 
mechanical ventilation for 32 days, underwent a second 
bronchoscopic evaluation, required a percutaneous trache-
ostomy (and subsequent decannulation), and underwent en-
doscopic gastrostomy tube placement (and removal). She 
was discharged from the hospital after 55 days and ulti-
mately recovered completely.
To determine the etiology of the clinical syndrome for 
the patient reported here, molecular diagnostic testing of 
respiratory tract clinical specimens was required. Institu-
tional review board approval was obtained for molecular 
diagnostics and sequencing of the patient’s nasopharyngeal 
swab specimens and bronchoalveolar lavage (BAL) fluid 
samples. The FilmArray platform is capable of detecting 
enteroviral infections caused by EV-D68 but cannot differ-
entiate between rhinoviruses and enteroviruses (5). Confir-
mation of EV-D68 requires EV-D68–specific PCR (6).
A novel, research-based diagnostic modality that is ca-
pable of rapid identification of viral pathogens directly from 
clinical specimens is the combination of PCR and electro-
spray ionization mass spectrometry (ESI-MS) (7), which was 
instrumental in early recognition of the novel pandemic strain 
of influenza A(H1N1) virus that emerged in 2009 (8). For a 
variety of viral pathogens, PCR/ESI-MS sensitivity is 94% 
and specificity is 98% (9). In this case, PCR/ESI-MS detect-
ed a human enterovirus from the right middle lobe and left 
lingular segment BAL fluid samples. For the assay, 2 primer 
pairs were used; both confirmed the presence of human en-
terovirus, but only 1 matched the signatures for EV-D68.
For confirmation, we pursued testing with EV-D68–
specific PCR, which was performed by the Special Proj-
ects Laboratory of the Washington University Department 
of Pediatrics. This assay amplifies a segment of the viral 
protein 1 gene, which enables discrimination of EV-D68 
from other enteroviruses and rhinoviruses (K.M. Wylie et 
al., unpub. data). The nasopharyngeal swab sample and the 







PCR/ESI-MS of BAL fluid followed by EV-D68–spe-
cific PCR testing of 1 nasopharyngeal swab and 2 BAL 
fluid samples confirmed our clinical suspicion of ARDS 
secondary to EV-D68 in an adult. The patient’s history of 
contact with sick family members and clinical signs (non-
productive cough, nausea, and vomiting) were suggestive 
of a viral infection. Lessons learned from the emergence of 
swine-origin influenza A(H1N1)pdm09 virus and recogni-
tion (in the midst of the pandemic) that younger age and 
obesity were risk factors for severe disease were also sug-
gestive of a viral respiratory infection.
We are developing a specific rapid molecular assay 
for EV-D68, which should help clinicians recognize when 
EV-D68 is present in the community. During those times, 
EV-D68 infection should be included in the differential di-
agnosis of severe respiratory infection. Documentation of 
EV-D68 infection may help with clinical management for 
individual patients and minimize unnecessary use of anti-
microbial drugs within communities.
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To the Editor: Over the past 4 years, outbreaks caused 
by enterovirus type D68 (EV-D68) infection have occurred 
in many parts of the world (1); this virus can cause severe 
respiratory tract infections (RTIs) in children. This public 
health concern has been boosted by the recent outbreaks 
of EV-D68 infection in the United States (http://www.cdc.
gov/non-polio-enterovirus/outbreaks/EV-D68-outbreaks.
html). Outbreaks associated with novel EV-D68 have also 
been reported during 2006–2012 in China (2,3). Howev-
er, since 2012, no EV-D68 infections in China have been 
reported. Whether the EV-D68 outbreaks in the United 
States affected those in China is unclear. Continuous char-
acterization of EV-D68 epidemics is therefore necessary 
for purposes of early alert and for facilitating control mea-
sure decisions.
To determine EV-D68 prevalence in China, we 
screened for EV-D68 infections in 2014 in Beijing, Chi-
na. We tested patients with RTI during August–November 
2014, reported by the Respiratory Virus Surveillance Sys-
tem, established by Beijing Center for Disease Prevention 
and Control. The System covers 30 sentinel hospitals in all 
16 districts of Beijing. We obtained 1,478 clinical speci-
mens (1,034 nasopharyngeal swab and 444 sputum). Pa-
tient ages ranged from 8 months to 93 years (median 33.5 
years, mean 37.9 years). Enteroviruses and other known 
respiratory viruses were detected by real-time PCR (4). A 
total of 70 enterovirus-positive samples were identified. 
Other respiratory viruses detected were 89 rhinoviruses, 87 
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